Cargando…
Commentary: Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
Autores principales: | Majagi, Shreya, Mangat, Sharan, Chu, Xiang-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294732/ https://www.ncbi.nlm.nih.gov/pubmed/35865964 http://dx.doi.org/10.3389/fphar.2022.938748 |
Ejemplares similares
-
Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
por: Qi, Xin, et al.
Publicado: (2022) -
Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia
por: Fan, Feng, et al.
Publicado: (2022) -
Neuroprotective Effect for Cerebral Ischemia by Natural Products: A Review
por: Xie, Qian, et al.
Publicado: (2021) -
Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System
por: Zhong, Zhi-feng, et al.
Publicado: (2019) -
Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
por: Oken, Adam C., et al.
Publicado: (2022)